ChemGenex
Showing 1 - 5 of 5
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +28 more
Dec 1, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +31 more
Nov 11, 2021
Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase, Blast Phase Trial in Houston (Homoharringtonine,
Terminated
- Myeloid Leukemia, Chronic
- +3 more
- Homoharringtonine
- Imatinib Mesylate
-
Houston, TexasUniv. of Texas M.D. Anderson Cancer Center
Jan 8, 2015
Hematologic Tumors Trial in Dallas (Omacetaxine)
Completed
- Hematologic Tumors
-
Dallas, TexasMary Crowley Cancer Research Center
May 9, 2014
Leukemia Trial in Houston (homoharringtonine, chemo)
Withdrawn
- Leukemia
- homoharringtonine
- chemotherapy
-
Houston, TexasM. D. Anderson Cancer Center at University of Texas
Mar 21, 2013